-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare
Overview ( as on 14/11/25 )
NAV
₹40.72
Last change
₹0.09 +0.0%
Fund Size (AUM)
6437.36 Cr
Performance
20.65% (5Y)
Fund Details
ICICI Pru Pharma Healthcare Diag Growth
as of 14/11/25
AUM
6437.36 Cr
Expense Ratio
1.87 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Pru Pharma Healthcare Diag Growth | 8.44% | 27.62% | 20.65% |
| BSE Healthcare TR INR | 1.4% | 23.01% | 18.25% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.88% |
Dr Reddy's Laboratories Ltd |
9.42% |
Divi's Laboratories Ltd |
8.5% |
Aurobindo Pharma Ltd |
7.62% |
Cipla Ltd |
6.61% |
Lupin Ltd |
5.4% |
Alkem Laboratories Ltd |
3.98% |
Biocon Ltd |
3.28% |
Mankind Pharma Ltd |
2.79% |
Zydus Lifesciences Ltd |
2.67% |
Sector Allocation
Healthcare |
97.59% |
Basic Materials |
1.21% |
Financial |
1.2% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
20.65% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
19.96% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
19.35% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
19.35% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
17.42% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
17.42% (5Y)
-
